The Supreme Court has acted to preserve access to the widely used abortion pill mifepristone. The justices issued a decision that keeps the medication available under current distribution methods.
This ruling means that restrictions on the abortion pill will remain frozen, allowing for continued access via telehealth services. Furthermore, the court's action ensures that the distribution of mifepristone by mail will also continue without new limitations.
The decision prevents a ban on receiving the abortion pill through postal services from taking effect. This is a developing story and will be updated as details emerge.
